157 related articles for article (PubMed ID: 1319386)
1. CA-125, placental alkaline phosphatase and tissue polypeptide antigen as preoperative serum markers in ovarian carcinoma.
Toftager-Larsen K; Hørding U; Dreisler A; Daugaard S; Lund B; Bock J; Lundvall F; Frederiksen K; Nørgaard-Pedersen B
Gynecol Obstet Invest; 1992; 33(3):177-82. PubMed ID: 1319386
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis.
Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Kiviranta A; Hallman K; Holm L; Weiner E; Tamsen L
Gynecol Oncol; 1990 Oct; 39(1):16-25. PubMed ID: 2227569
[TBL] [Abstract][Full Text] [Related]
3. Placental alkaline phosphatase (PLAP)/PLAP-like alkaline phosphatase as tumour marker in relation to CA 125 and TPA for ovarian epithelial tumours.
Stigbrand T; Riklund K; Tholander B; Hirano K; Lalos O; Stendahl U
Eur J Gynaecol Oncol; 1990; 11(5):351-60. PubMed ID: 2097151
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase in patients with ovarian carcinoma: influence of histological type, grade of differentiation, and clinical stage of disease.
Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Tamsen L
Gynecol Oncol; 1990 Oct; 39(1):26-33. PubMed ID: 2227570
[TBL] [Abstract][Full Text] [Related]
5. CA 125, placental alkaline phosphatase, and tissue polypeptide antigen in the monitoring of ovarian carcinoma. A comparative study of three different tumor markers.
Hørding U; Toftager-Larsen K; Dreisler A; Lund B; Daugaard S; Lundvall F; Arends J; Winkel P; Rørth M
Gynecol Obstet Invest; 1990; 30(3):178-83. PubMed ID: 2265805
[TBL] [Abstract][Full Text] [Related]
6. Comparison of CA 125 and placental alkaline phosphatase as ovarian tumor markers.
Heinonen PK; Kallioniemi OP; Koivula T
Tumori; 1987 Jun; 73(3):301-2. PubMed ID: 3474819
[TBL] [Abstract][Full Text] [Related]
7. [Value of CA 125 in comparison to conventional tumor markers in ovarian cancer].
Paulick R; Kaesemann H; Caffier H
Geburtshilfe Frauenheilkd; 1986 Aug; 46(8):509-14. PubMed ID: 2875919
[TBL] [Abstract][Full Text] [Related]
8. [Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer].
Schröck R; Hafter R; Schmid L; Babic R; Ulm K; Gössner W; Graeff H
Geburtshilfe Frauenheilkd; 1986 Jan; 46(1):1-10. PubMed ID: 2420679
[TBL] [Abstract][Full Text] [Related]
9. [New prospects in the combined use of tumor markers in epithelial neoplasms of the ovary].
Indraccolo SR; Cecchi A; Thodos A; Brandi S; Carta G
Ann Ostet Ginecol Med Perinat; 1991; 112(1):36-40. PubMed ID: 1929097
[TBL] [Abstract][Full Text] [Related]
10. Tumor markers in bronchogenic carcinoma. An evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase and pseudouridine.
Rasmuson T; Björk GR; Damber L; Holm SE; Jacobsson L; Jeppsson A; Stigbrand T; Westman G
Acta Radiol Oncol; 1983; 22(3):209-14. PubMed ID: 6312760
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of seven different tumour markers for the establishment of tumour marker panels in gynecologic malignancies.
Avall Lundqvist E; Nordström L; Sjövall K; Eneroth P
Eur J Gynaecol Oncol; 1989; 10(6):395-405. PubMed ID: 2627971
[TBL] [Abstract][Full Text] [Related]
12. Sialyl-Tn, sialyl-Lewis Xi, CA 19-9, CA 125, carcinoembryonic antigen, and tissue polypeptide antigen in differentiating ovarian cancer from benign tumors.
Inoue M; Fujita M; Nakazawa A; Ogawa H; Tanizawa O
Obstet Gynecol; 1992 Mar; 79(3):434-40. PubMed ID: 1346716
[TBL] [Abstract][Full Text] [Related]
13. Coordinate elevation of serum markers in ovarian cancer but not in benign disease.
Bast RC; Knauf S; Epenetos A; Dhokia B; Daly L; Tanner M; Soper J; Creasman W; Gall S; Knapp RC
Cancer; 1991 Oct; 68(8):1758-63. PubMed ID: 1913520
[TBL] [Abstract][Full Text] [Related]
14. Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype.
Kelly PJ; Archbold P; Price JH; Cardwell C; McCluggage WG
J Clin Pathol; 2010 Feb; 63(2):169-73. PubMed ID: 20154039
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of serum sialyl Tn antigen in patients with gynecological cancer. STN Study Group].
Noda K; Shiota M; Tanizawa O; Inoue M; Tenjin Y; Sugishita T; Yakushiji M; Miyoshi T; Nozawa S; Sakuma T
Gan To Kagaku Ryoho; 1991 Jul; 18(8):1287-96. PubMed ID: 2069400
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttila I
Anticancer Res; 1993; 13(5C):1883-7. PubMed ID: 8267397
[TBL] [Abstract][Full Text] [Related]
17. Independent expression in serum of three tumour-associated antigens: CA 125, placental alkaline phosphatase and HMFG2 in ovarian carcinoma.
Ward BG; Cruickshank DJ; Tucker DF; Love S
Br J Obstet Gynaecol; 1987 Jul; 94(7):696-8. PubMed ID: 2441739
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase, and modified nucleosides as biological markers in malignant lymphomas.
Rasmuson T; Björk GR; Damber L; Holm SE; Jacobsson L; Jeppsson A; Littbrand B; Stigbrand T; Westman G
Recent Results Cancer Res; 1983; 84():331-43. PubMed ID: 6342073
[TBL] [Abstract][Full Text] [Related]
19. [Ovarian cancer--a comparison between CT diagnosis and serum tumor markers].
Wakabayashi Y; Yachida M; Akata S; Kawana K; Kotake F; Kakizaki D; Abe K; Negishi N; Akiya K
Gan No Rinsho; 1988 Jan; 34(1):52-6. PubMed ID: 3422324
[TBL] [Abstract][Full Text] [Related]
20. Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma.
Panza N; Pacilio G; Campanella L; Peluso G; Battista C; Amoriello A; Utech W; Vacca C; Lombardi G
Cancer; 1988 Jan; 61(1):76-83. PubMed ID: 2446734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]